Company
Avivo Biomedical Inc.
Avivo - Changing blood types and minds
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Avivo, formerly known as ABOzymes is an early-stage enterprise with an innovative, unique, and proprietary platform that enables a world where a person’s blood type is no longer the first constraint when patients need life-saving organ transplants or blood transfusions.
Loading relationship preview